has been cited by the following articles in journals that are participating in CrossRef's forward linking service: |
||
| DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells K. V. Rosinski, N. Fujii, J. K. Mito, K. K. W. Koo, S. M. Xuereb, O. Sala-Torra, J. S. Gibbs, J. P. Radich, Y. Akatsuka, and B. J. Van den Eynde Blood (2008) 111: 4817 Link to Article |
||
| Using allogeneic stem cell/T-cell grafts to cure hematologic malignancies Andrew R Rezvani and Rainer Storb Expert Opinion on Biological Therapy (2008) 8: 161 Link to Article |
||
| Allogeneic HLA-Matched Donor Dendritic Cells Loaded with Patient Leukemic Blasts Preferentially Induce CD4-Positive Leukemia-Reactive
Donor Lymphocytes Anna-Katharina Thomas-Kaskel, Tatiana Gil Alves Portugal, Dieter Herchenbach, Leonora Houet, Hendrik Veelken, and Jürgen Finke Acta Haematologica (2007) 117: 226 Link to Article |
||
| Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+CD3+ count reconstitution is associated
with survival U Koehl, K Bochennek, S Y Zimmermann, T Lehrnbecher, J Sörensen, R Esser, C Andreas, C Kramm, H P Grüttner, and E Falkenberg Bone Marrow Transplantation (2007) 39: 269 Link to Article |
||
| Identification of HLA-CW3, GNAS and IMPA as Cytotoxic T-Lymphocyte (CTL) Target Antigens Using an Allogeneic Mixed Lymphocyte
Tumor Cell Culture (MLTC) System and Subsequent cDNA Library Screening Joanne M. Wroblewski and John R. Yannelli Cancer Biotherapy & Radiopharmaceuticals (2007) 22: 206 Link to Article |
||
| Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions Yoshiki Akatsuka, Yasuo Morishima, Kiyotaka Kuzushima, Yoshihisa Kodera, and Toshitada Takahashi Cancer Science (2007) 98: 1139 Link to Article |
||
| Cancer stem cells ? an old idea that?s new again: implications for the diagnosis and treatment of breast cancer Lynda Li Song and Lucio Miele Expert Opinion on Biological Therapy (2007) 7: 431 Link to Article |
||
| A Single Minor Histocompatibility Antigen Encoded by UGT2B17 and Presented by Human Leukocyte Antigen-A*2902 and -B*4403 Seitaro Terakura, Makoto Murata, Edus H. Warren, Alessandro Sette, John Sidney, Tomoki Naoe, and Stanley R. Riddell Transplantation (2007) 83: 1242 Link to Article |
||
| The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303 H. Torikai, Y. Akatsuka, M. Miyazaki, A. Tsujimura, Y. Yatabe, T. Kawase, Y. Nakao, K. Tsujimura, K. Motoyoshi, and Y. Morishima British Journal of Haematology (2006) 134: 406 Link to Article |
||
| Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic
leukaemia in NOD/scid mice L Hambach, B A Nijmeijer, Z Aghai, M L J van Schie, M H M Wauben, J H F Falkenburg, and E Goulmy Leukemia (2006) 20: 371 Link to Article |
||
| Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter? John Goldman and Myrtle Gordon Leukemia & Lymphoma (2006) 47: 1 Link to Article |
||
| T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation Johannes Schetelig, Alexander Kiani, Marc Schmitz, Gerhard Ehninger, and Martin Bornhäuser Cancer Immunology Immunotherapy (2005) 54: 1043 Link to Article |
||
| Human cytotoxic T lymphocytes specific for Wilms??? tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells
in non-obese diabetic-severe combined immunodeficient recipients Liquan Gao, Shao-an Xue, Robert Hasserjian, Finbarr Cotter, Jaspal Kaeda, John M. Goldman, Fancesco Dazzi, and Hans J. Stauss Transplantation (2003) 75: 1429 Link to Article |
||
| Cellular vaccine therapy for cancer Anne C Armstrong, David Eaton, and Joanne C Ewing Expert Review of Vaccines (2002) 1: 303 Link to Article |
||
| Expression of minor histocompatibility antigen, HA-1, in solid tumor cells Nobuharu Fujii, Akio Hiraki, Kazuma Ikeda, Yasushi Ohmura, Isao Nozaki, Katsuji Shinagawa, Fumihiko Ishimaru, Katsuyuki Kiura, Nobuyoshi Shimizu, and Mitsune Tanimoto Transplantation (2002) 73: 1137 Link to Article |
||
| Immune reconstitution at 6 months following t-cell depleted hematopoietic stem cell transplantation is predictive for treatment
outcome Nicolas Novitzky, Glenda M. Davison, Geoffrey Hale, and Herman Waldmann Transplantation (2002) 74: 1551 Link to Article |
||
| Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias Mark W. Lowdell, Lawrence Lamb, Christine Hoyle, Andrea Velardi, and H. Grant Prentice British Journal of Haematology (2001) 114: 11 Link to Article |
||
| Leukemia vaccines James N. Kochenderfer and Jeffrey J. Molldrem Current Oncology Reports (2001) 3: 193 Link to Article |
||
Karl Peggs and Stephen Mackinnon Current Opinion in Hematology (2001) 8: 349 Link to Article |
||
Loredana Ruggeri, Marusca Capanni, Massimo Martelli, and Andrea Velardi Current Opinion in Hematology (2001) 8: 355 Link to Article |
||
Hendrik Veelken Current Opinion in Organ Transplantation (2001) 6: 272 Link to Article |
||
Felipe Prosper and Giovanni Rosti Current Opinion in Organ Transplantation (2001) 6: 278 Link to Article |
||
| Biological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive
chemotherapy? Oystein Wendelboe and Oystein Bruserud Expert Opinion on Biological Therapy (2001) 1: 1005 Link to Article |
||
| Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation,
an evolving strategy for adoptive immunotherapy Richard Champlin, Issa Khouri, Avichai Shimoni, James Gajewski, Steven Kornblau, Jeffrey Molldrem, Naoto Ueno, Sergio Giralt, and Paolo Anderlini British Journal of Haematology (2000) 111: 18 Link to Article |
||